Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.

Vistisen, Simon T; Bodilsen, Jacob; Scheeren, Thomas W L; Simonsen, Ulf

Vistisen, Simon T; Bodilsen, Jacob; Scheeren, Thomas W L; Simonsen, Ulf.

Vistisen ST; From the Department of Clinical Medicine, Aarhus University, Aarhus (STV), Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark (JB), Department of Anaesthesiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands (TWLS) and Department of Biomedicine, Aarhus University, Aarhus, Denmark (US).

Eur J Anaesthesiol ; 37(9): 739-742, 2020 09.

Article in English | MEDLINE | ID: covidwho-707479

Subject(s)

Angiotensin II Type 1 Receptor Blockers/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Renin-Angiotensin System/drug effects; Angiotensin II Type 1 Receptor Blockers/adverse effects; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Antihypertensive Agents/therapeutic use; COVID-19; Coronavirus Infections/complications; Humans; Observational Studies as Topic; Pandemics; Pneumonia, Viral/complications; Prognosis; Risk Assessment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Renin-Angiotensin System / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin II Type 1 Receptor Blockers Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Eur J Anaesthesiol Journal subject: Anesthesiology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google